Clinical Trials Browser

Mental Disorders × CNS × Clear all

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT04322734 2024-12-27

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Recruiting

500 enrolled

CNS

Autism Spectrum Disorder, Mental Disorders, Brain Neoplasms, Epilepsy, Mitochondrial Diseases

NCT05618990 2024-07-10

OPT-IRM

Recruiting

300 enrolled

CNS

Mental Disorders, Brain Neoplasms, Stroke

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT05393492 2022-05-26

GREMO-LCA

Phase NA Unknown

77 enrolled

CNS

Mental Disorders, Brain Injuries, Brain Neoplasms, Hypoxia, Brain, Encephalitis, Ischemia, Meningitis, Stroke

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

CNS

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

Clinical Trials

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

OPT-IRM

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

GREMO-LCA

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2